Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2018

01-01-2018 | Original Article

Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease

Authors: K. Furuuchi, A. Ito, T. Hashimoto, S. Kumagai, T. Ishida

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Chronic pulmonary aspergillosis (CPA) is associated with mortality in patients with Mycobacterium avium complex lung disease (MAC-LD). An Aspergillus-positive respiratory specimen often reflects colonization, and thus the clinical significance of Aspergillus isolation in MAC-LD patients is not well understood. The objective of this study was to investigate the clinical characteristics and outcomes of MAC-LD patients in whom Aspergillus was isolated from respiratory specimens. We performed a retrospective review of the medical records of 329 MAC-LD patients. We compared the characteristics and mortality rates between patients with Aspergillus isolation and those without. All Aspergillus species detected from respiratory specimens within the follow-up period were reviewed. Aspergillus was detected in 40 (12.2%) of the 329 patients. There were no significant differences in the clinical characteristics and mortality rates between patients with and without Aspergillus isolation. Among the 40 patients with Aspergillus isolation, 9 (22.5%) developed CPA. CPA was most often caused by A. fumigatus. In the 40 Aspergillus-positive patients, patients with A. fumigatus isolation had a significantly higher mortality rate than those without (P < 0.001). The multivariate Cox proportional hazards model showed older age (P = 0.050), presence of respiratory comorbidities (P = 0.008), hypoalbuminemia (P < 0.001), and isolation of A. fumigatus (P = 0.005) to be prognostic factors for mortality in MAC-LD patients. There was no significant difference in the mortality rates between patients with Aspergillus isolation and those without. However, isolation of A. fumigatus may be associated with poor prognosis in MAC-LD patients.
Literature
1.
go back to reference Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR (2012) Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries. Am J Respir Crit Care Med 185:881–886CrossRefPubMedPubMedCentral Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR (2012) Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries. Am J Respir Crit Care Med 185:881–886CrossRefPubMedPubMedCentral
2.
go back to reference Prevots DR, Shaw PA, Strickland D, Jackson LA, Reabel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN (2010) Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 182:970–976CrossRefPubMedPubMedCentral Prevots DR, Shaw PA, Strickland D, Jackson LA, Reabel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN (2010) Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 182:970–976CrossRefPubMedPubMedCentral
3.
go back to reference Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV, Abdallah S, Shah P, Wilson R (2005) Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60:1045–1051CrossRefPubMedPubMedCentral Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV, Abdallah S, Shah P, Wilson R (2005) Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60:1045–1051CrossRefPubMedPubMedCentral
4.
go back to reference Angrill J, Agusti C, de Celis R, Rano A, Gonzalez J, Sole T, Xaubet A, Rodriguez-Roisin R, Torres A (2002) Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 57:15–19CrossRefPubMedPubMedCentral Angrill J, Agusti C, de Celis R, Rano A, Gonzalez J, Sole T, Xaubet A, Rodriguez-Roisin R, Torres A (2002) Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 57:15–19CrossRefPubMedPubMedCentral
5.
go back to reference Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J (2007) Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 132:1565–1572CrossRefPubMed Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J (2007) Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 132:1565–1572CrossRefPubMed
7.
go back to reference Godet C, Philippe B, Laurent F, Cadranel J (2014) Chronic pulmonary aspergillosis: an update on diagnosis and treatment. Respiration 88:162–174CrossRefPubMed Godet C, Philippe B, Laurent F, Cadranel J (2014) Chronic pulmonary aspergillosis: an update on diagnosis and treatment. Respiration 88:162–174CrossRefPubMed
8.
go back to reference Smith NL, Denning DW (2011) Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 37:865–872CrossRefPubMed Smith NL, Denning DW (2011) Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 37:865–872CrossRefPubMed
9.
go back to reference Kobashi Y, Fukuda M, Yoshida K, Miyashita N, Niki Y, Oka M (2006) Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology 11:809–813CrossRefPubMed Kobashi Y, Fukuda M, Yoshida K, Miyashita N, Niki Y, Oka M (2006) Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology 11:809–813CrossRefPubMed
10.
go back to reference Zoumot Z, Boutou AK, Gill S, van Zeller M, Hansell DM, Wells AU, Wilson R, Loebinger MR (2014) Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology 19:714–722CrossRefPubMed Zoumot Z, Boutou AK, Gill S, van Zeller M, Hansell DM, Wells AU, Wilson R, Loebinger MR (2014) Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology 19:714–722CrossRefPubMed
11.
go back to reference Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, Tashiro M, Saijo T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Tashiro T, Kohno S, Yanagihara K, Izumikawa K (2016) The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol 54:120–127CrossRefPubMed Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, Tashiro M, Saijo T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Tashiro T, Kohno S, Yanagihara K, Izumikawa K (2016) The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol 54:120–127CrossRefPubMed
12.
go back to reference Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO (2006) Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 21:322–327CrossRefPubMed Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO (2006) Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 21:322–327CrossRefPubMed
13.
go back to reference Shi Y, Liu HZ, Wang XT, Liu Y, Rui X, Tang B, Chai WZ, Zhao H (2009) The clinical significance of Aspergillus isolation from airway samples in critically ill patients. Zhonghua Jie He He Hu Xi Za Zhi 32:444–449PubMed Shi Y, Liu HZ, Wang XT, Liu Y, Rui X, Tang B, Chai WZ, Zhao H (2009) The clinical significance of Aspergillus isolation from airway samples in critically ill patients. Zhonghua Jie He He Hu Xi Za Zhi 32:444–449PubMed
14.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416CrossRefPubMed
15.
go back to reference Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y (2012) Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 185:575–583CrossRefPubMed Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y (2012) Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 185:575–583CrossRefPubMed
16.
go back to reference Furuuchi K, Ito A, Hashimoto T, Kumagai S, Ishida T (2017) Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients. Int J Tuberc Lung Dis 21:452–457CrossRefPubMed Furuuchi K, Ito A, Hashimoto T, Kumagai S, Ishida T (2017) Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients. Int J Tuberc Lung Dis 21:452–457CrossRefPubMed
17.
go back to reference Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C, European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47:45–68CrossRefPubMed Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C, European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47:45–68CrossRefPubMed
18.
go back to reference Kumagai S, Ito A, Hashimoto T, Marumo S, Tokumasu H, Kotani A, Yamaki H, Shirata M, Furuuchi K, Fukui M, Ishida T (2017) Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study. BMC Infect Dis 17:436CrossRefPubMedPubMedCentral Kumagai S, Ito A, Hashimoto T, Marumo S, Tokumasu H, Kotani A, Yamaki H, Shirata M, Furuuchi K, Fukui M, Ishida T (2017) Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study. BMC Infect Dis 17:436CrossRefPubMedPubMedCentral
19.
go back to reference Kunst H, Wickremasinghe M, Wells A, Wilson R (2006) Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 28:352–357CrossRefPubMed Kunst H, Wickremasinghe M, Wells A, Wilson R (2006) Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 28:352–357CrossRefPubMed
20.
go back to reference Lowes D, Al-Shair K, Newton PJ, Morris J, Harris C, Rautemaa-Richardson R, Denning DW (2017) Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J 49:1601062CrossRefPubMed Lowes D, Al-Shair K, Newton PJ, Morris J, Harris C, Rautemaa-Richardson R, Denning DW (2017) Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J 49:1601062CrossRefPubMed
21.
go back to reference Soubani AO, Khanchandani G, Ahmed HP (2004) Clinical significance of lower respiratory tract Aspergillus culture in elderly hospitalized patients. Eur J Clin Microbiol Infect Dis 23:491–494CrossRefPubMed Soubani AO, Khanchandani G, Ahmed HP (2004) Clinical significance of lower respiratory tract Aspergillus culture in elderly hospitalized patients. Eur J Clin Microbiol Infect Dis 23:491–494CrossRefPubMed
24.
go back to reference Wasylnka JA, Moore MM (2000) Adhesion of Aspergillus species to extracellular matrix proteins: evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun 68:3377–3384CrossRefPubMedPubMedCentral Wasylnka JA, Moore MM (2000) Adhesion of Aspergillus species to extracellular matrix proteins: evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun 68:3377–3384CrossRefPubMedPubMedCentral
25.
go back to reference Tashiro T, Izumikawa K, Tashiro M, Takazono T, Morinaga Y, Yamamoto K, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Kohno S (2011) Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol 49:581–587PubMed Tashiro T, Izumikawa K, Tashiro M, Takazono T, Morinaga Y, Yamamoto K, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Kohno S (2011) Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol 49:581–587PubMed
26.
go back to reference Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D (2016) Microbial colonization and lung function in adolescents with cystic fibrosis. J Cyst Fibros 15:340–349CrossRefPubMed Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D (2016) Microbial colonization and lung function in adolescents with cystic fibrosis. J Cyst Fibros 15:340–349CrossRefPubMed
27.
go back to reference Smith K, Rajendran R, Kerr S, Lappin DF, Mackay WG, Williams C, Ramage G (2015) Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures. Med Mycol 53:645–655CrossRefPubMed Smith K, Rajendran R, Kerr S, Lappin DF, Mackay WG, Williams C, Ramage G (2015) Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures. Med Mycol 53:645–655CrossRefPubMed
Metadata
Title
Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease
Authors
K. Furuuchi
A. Ito
T. Hashimoto
S. Kumagai
T. Ishida
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-3105-6

Other articles of this Issue 1/2018

European Journal of Clinical Microbiology & Infectious Diseases 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.